GSA Capital Partners LLP Grows Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
GSA Capital Partners LLP lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 136.8% during the 1st quarter, Holdings Channel reports. The institutional investor owned 87,284 shares of the company’s stock after buying an additional 50,427 shares during the period. GSA Capital Partners LLP’s holdings in Syndax Pharmaceuticals were worth $1,072,000 at […]
More Stories
Gulf States Say They’ve Shot Down More Than 1,500 Iranian Missiles, Drones
By John Haughey Five Persian Gulf nations that host U.S. military installations claim they have collectively shot down more than...
FBI Confirms Terrorism Task Force Investigating Texas Bar Shooting That Left 2 Dead
By Jack Phillips The FBI on March 1 stated that its terrorism task force has joined an investigation into a...
After Khamenei’s Death, Continued US–Israeli Strikes Push Iran’s Regime to Brink
By Emel Akan and Jacob Burg WASHINGTON—President Donald Trump on March 1 praised the joint U.S.–Israel military operation that killed...
Trump Announces US Military Sank 9 Iranian Navy Ships
By Jack Phillips President Donald Trump on Sunday afternoon said that the U.S. military has sunk nine Iranian naval ships...
State Department Urges Vigilance for Americans Overseas Amid Iran Conflict
By Bill Pan The U.S. Department of State is urging Americans worldwide, particularly those in the Middle East, to exercise...
Trump Admin Seeks Months-Long Pause on Tariff Refunds
By Bill Pan The Trump administration says it needs months of additional time to weigh its steps, as a wave...